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exploiting this potent tumor-suppressor network for
treating cancer.
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The Enigmatic Role
of Sir2 in Aging
In this issue of Cell, Longo and colleagues (Fabrizio
et al., 2005) examine the role of Sir2, a histone deacet-
ylase, in chronological aging in yeast by measuring
the long-term survival of nondividing cells. In contrast
to measurements of aging for mitotic cells, cell survival
in the nonmitotic state is decreased by Sir2 activity
under conditions that mimic calorie restriction.
The replicative aging of the budding yeast Saccharo-
myces cerevisiae has been measured by the number of
daughter cells that one mother cell can produce. More
than a decade ago, a screen for genes that determine
yeast replicative life span identified the SIR complex
(including the Sir2 histone deacetylase) as a regulator
of replicative aging (Kennedy et al., 1995). Since then,
an extensive body of work, largely from Leonard Guar-
ente and his colleagues, has demonstrated that Sir2
activity correlates with yeast replicative life span: SIR2
deletion strains are short lived, whereas strains that
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aoverexpress SIR2 are long lived (Kaeberlein et al.,
1999).
A second model of yeast aging has been developed,
termed chronological aging, in which life span is mea-
sured by the length of time that cells can survive in a
nondividing state (Fabrizio et al., 2001). Whereas repli-
cative aging may be a useful model for mammalian
cells that remain mitotically active, chronological aging
may more effectively model postmitotic cells. In this
study, Fabrizio et al. (2005) examine the role of Sir2 in
chronological aging, finding—in apparent contrast to
replicative aging—that Sir2 interferes with the life-span
extension conferred by the exposure of cells to hypoca-
loric media or by mutations that impair the cell’s ability
to respond to nutrients.
In yeast, Sir2 promotes replicative longevity by re-
pressing the recombination of repetitive ribosomal DNA
(rDNA) and the subsequent formation of extrachromo-
somal rDNA circles (ERCs) (Figure 1A) (Kaeberlein et
al., 1999). The accumulation of ERCs is thought to be
one cause of replicative senescence; however, there is
no reason to believe that ERCs play a role in yeast
chronological aging. How then might Sir2 affect aging
in nondividing yeast cells? Fabrizio et al. (2005) present
evidence for three possible mechanisms (Figure 1A).
First, deletion of SIR2 in nutrient-deprived cells was
found to decrease the rate of DNA mutations that accu-
mulate with age in postmitotic conditions. This con-
trasts with the role of Sir2 in mitotically active cells,
where it promotes genome stability by repressing re-
combination (Blander and Guarente, 2004). Second, Fa-
brizio et al. (2005) find that the SIR2 deletion strain ex-
hibits increased stress resistance, including resistance
to both heat shock and oxidative stress, compared to
wild-type yeast. Finally, these authors report that the
IR2 deletion strain has elevated levels of the alcohol
ehydrogenase, Adh2. Mitotically active yeast cells
enerate energy primarily through fermentation, lead-
ng to the production of ethanol. As fermentable carbon
ources become scarce and ethanol accumulates,
east undergo a metabolic shift and begin to use etha-
ol as an energy source, only entering stationary phase
fter ethanol levels are largely depleted. Fabrizio et al.
2005) speculate that in the absence of Sir2, increased
lcohol dehydrogenase activity leads to more rapid
thanol degradation and entry into a more stable post-
itotic state. The mechanism by which Sir2 negatively
egulates Adh2 levels as cells enter a postmitotic state
s yet to be determined.
The finding that Sir2 limits chronological life span un-
er nutrient-restricted conditions runs counter to studies
f yeast replicative aging, as well as studies of Sir2 or-
hologs in worms and flies, where increased Sir2 activ-
ty enhances longevity (Blander and Guarente, 2004).
owever, evidence that the story may be more compli-
ated than previously thought comes as no surprise to
hose familiar with the enigmatic Sir2. First, the mecha-
ism by which Sir2 slows yeast replicative aging, by
nhibiting the formation of ERCs, is almost certainly not
elevant in higher organisms. Thus, we are left to pon-
er how (and why) Sir2-family proteins might have
volved different molecular functions in determining
ongevity. Second, the question of whether Sir2 plays
ny role in replicative life-span extension by calorie re-
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549Figure 1. The Enigmatic Role of Sir2 in Aging
(A) The figure depicts reported functions of
Sir2 in mitotic and postmitotic cells. In yeast,
Sir2 promotes replicative longevity by re-
pressing the recombination of repetitive ri-
bosomal DNA (rDNA) and the subsequent
formation of extrachromosomal rDNA circles
(ERCs). Sir2 decreases chronological lon-
gevity, perhaps by promoting DNA damage,
inhibiting stress resistance, and/or inhibiting
the activation of the alcohol dehydrogenase,
Adh2. Sir2 also has other cellular functions
that are apparently unrelated to its aging-
related roles, such as transcriptional silenc-
ing of HM mating-type loci and telomeric
genes, DNA damage response in mitotic
cells, and its reported involvement in the
mother cell-specific retention of oxidatively
damaged proteins.
(B) This model depicts the factors and path-
ways that regulate replicative and chrono-
logical aging. Although Sir2 appears to affect
replicative and chronological aging differently,
increasing evidence suggests that the highly
conserved kinases Tor, Sch9, and PKA regu-
late both replicative and chronological aging
in response to nutrient availability.striction also remains a perplexing topic. Sir2 was ini-
tially proposed to be an essential downstream mediator
of calorie restriction, but more recent findings indicate
that Sir2 is not required for calorie restriction as long
as ERC levels are kept low (Kaeberlein et al., 2004).
In fact, at least in some genetic backgrounds, calorie
restriction increases life span to a much greater extent
in cells lacking both Sir2 and the rDNA replication fork
blocking protein, Fob1, than it does in wild-type cells.
Finally, the relationship between Sir2 and calorie re-
striction in higher eukaryotes remains murky. In flies,
dSir2 is reported to be required for life-span extension
by calorie restriction (Blander and Guarente, 2004),
whereas evidence from studies with worm Sir2.1 sug-
gests otherwise (M.K., unpublished data). Clearly, more
studies need to be performed before any conclusions
can be drawn concerning direct links between Sir2 or-
thologs and calorie restriction.
The results of Fabrizio et al. (2005) suggest that,
rather than slowing aging, Sir2 proteins might actually
accelerate aging in at least some types of mammalian
cells and tissues. Although regulation of alcohol dehy-
drogenase is unlikely to play a direct role in mammalian
aging, Fabrizio et al. (2005) speculate that Sirt1, the
mammalian Sir2 ortholog, may play a similar role
through its reported ability to regulate glucose and fat
metabolism (Fabrizio et al., 2005; Picard et al., 2004).
Most mice deficient in Sirt1 die during embryonic de-
velopment; however, those animals that reach adult-
hood appear largely normal. This begs the question of
whether adult mice lacking Sirt1 will have a short life
span (as might be predicted from yeast replicative
aging) or a long life span (as might be predicted from
yeast chronological aging), or neither. Although the
life span of these animals has not yet been reported,
Sirt1−/− fibroblasts are resistant to senescence induced
by oxidative stress (Chua et al., 2005), and Sirt1−/− ani-
mals demonstrate several phenotypes consistent withlonger life span, including decreased body weight and
fat mass, smaller pituitary size, and lower levels of free
IGF-1 (Lemieux et al., 2005). The completion of life span
studies on Sirt1 knockout and transgenic animals
should be a priority and will likely enhance our under-
standing of this important gene and its role, if any, in
mammalian aging. Of particular interest will be studies
that examine whether mice lacking Sirt1 exhibit in-
creased life span under conditions of calorie restriction.
The findings of Fabrizio et al. (2005) regarding Sir2
also underscore how little is known about the genes
that influence the aging of both mitotic and postmitotic
cells. In yeast, three kinases appear to play a shared
role in regulating both types of aging (Figure 1B). Muta-
tions that result in decreased activity of PKA, Sch9, or
TOR increase both replicative and chronological life
span (Fabrizio et al., 2001, 2004; Kaeberlein et al., 2005;
R.W. Powers, M.K, B.K.K. and S. Fields, unpublished
data). Moreover, the long replicative life span of TOR
and Sch9 deletion strains is not further increased by
calorie restriction (Kaeberlein et al., 2005), suggesting
that TOR and Sch9 might mediate replicative life-span
extension by calorie restriction (Figure 1B). Importantly,
mutations that decrease the activity of the orthologous
proteins (Tor and Akt) in worms and flies also extend
life span, suggesting that these kinases share an evolu-
tionarily conserved role in responding to nutrients and
growth factors.
In yeast, as in higher eukaryotes, TOR, Sch9, and
PKA coordinate signals from nutrients and growth fac-
tors to regulate ribosome biogenesis, stress response,
cell size, autophagy, and other cellular processes. Prior
work from Longo and colleagues has suggested a
model for chronological life-span extension by deletion
of SCH9 that involves upregulation of the stress-
response transcription factors Msn2 and Msn4 (Fa-
brizio et al., 2001). However, Msn2 and Msn4 are not
required for replicative life-span extension in the SCH9
deletion strain (Fabrizio et al., 2004). Recent evidence
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genesis that accounts for the increase in replicative life
span upon deletion of SCH9 or TOR1 (Kaeberlein et al.,
2005). These studies suggest an intriguing model in
which similar nutrient-responsive signaling pathways
coordinate aging in mitotic and postmitotic cells, albeit
through different downstream effectors (Figure 1B).
A long-standing and still unresolved debate among
biogerontologists concerns whether the aging process
is controlled by a relatively small number of regulatory
pathways or whether aging results from many different
and cell-type-specific changes that occur over time.
Certainly different types of cells show different aging
characteristics. On the other hand, single gene muta-
tions can profoundly delay the rate of aging in all of the
well-studied model systems, including mice and rats. A
network in which regulatory proteins are used to coor-
dinate a wide range of downstream events important to
aging could unite both of these models and may help
to explain the wide range of aging phenotypes retarded
by calorie restriction. The combined use of both chron-
ological and replicative models of yeast aging will con-
tinue to be a powerful approach for dissecting the mo-
lecular mechanisms that coordinate longevity.
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